PA8450601A1 - Carprofeno selectivo para cox-2, para el tratamiento del dolor e inflamacion en perros - Google Patents
Carprofeno selectivo para cox-2, para el tratamiento del dolor e inflamacion en perrosInfo
- Publication number
- PA8450601A1 PA8450601A1 PA19988450601A PA8450601A PA8450601A1 PA 8450601 A1 PA8450601 A1 PA 8450601A1 PA 19988450601 A PA19988450601 A PA 19988450601A PA 8450601 A PA8450601 A PA 8450601A PA 8450601 A1 PA8450601 A1 PA 8450601A1
- Authority
- PA
- Panama
- Prior art keywords
- acids
- cox
- dogs
- treatment
- inhibitor
- Prior art date
Links
- 206010061218 Inflammation Diseases 0.000 title 1
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 title 1
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 title 1
- 230000004054 inflammatory process Effects 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 5
- 150000007513 acids Chemical class 0.000 abstract 3
- 239000003112 inhibitor Substances 0.000 abstract 3
- 241000282472 Canis lupus familiaris Species 0.000 abstract 2
- 102000010907 Cyclooxygenase 2 Human genes 0.000 abstract 2
- 108010037462 Cyclooxygenase 2 Proteins 0.000 abstract 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 abstract 2
- 150000001243 acetic acids Chemical class 0.000 abstract 2
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical class NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 abstract 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
TRATAMIENTO O PREVENCION DE PROCESOS Y ENFERMEDADES INFLAMATORIAS EN PERROS MEDIANTE LA ADMINISTRACION DE UN INHIBIDOR DE LA CICLO-OXIGENASA-2 (COX-2) PARA EL QUE LA POTENCIA TERAPEUTICA CI50 EN EL PERRO ES AL MENOS 20 VECES MAYOR QUE LA POTENCIA TERAPEUTICA CI50 PARA LA CICLOOXIGENASA-1 (COX-1) EN DICHO PERRO; DICHO INHIBIDOR ES UN MIEMBRO SELECCIONADO ENTRE EL GRUPO DE COMPUESTOS ANTIINFLAMATORIOS QUE CONSTA ESENCIALMENTE DE DERIVADOS DEL ACIDO SALICILICO; DERIVADOS DE P-AMINOFENOL; ACIDOS INDOL E INDENO ACETICOS;ACIDOS HETEROARIL ACETICOS; ACIDOS ARILPROPIONICOS; ACIDOS ANTRANILICOS; ACIDOS ENOLICOS; Y ALCANONAS; EL INHIBIDOR, EN PARTICULAR, ESTA COMPUESTO POR EL ENANTIOMERO (+) (S) DEL ACIDO 6-CLORO-ALFA-METIL-9H-CARBAZOL-2-ACETICO.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4563597P | 1997-05-05 | 1997-05-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PA8450601A1 true PA8450601A1 (es) | 2000-05-24 |
Family
ID=21939053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PA19988450601A PA8450601A1 (es) | 1997-05-05 | 1998-05-05 | Carprofeno selectivo para cox-2, para el tratamiento del dolor e inflamacion en perros |
Country Status (32)
| Country | Link |
|---|---|
| EP (1) | EP0988034A1 (es) |
| JP (1) | JP2000513020A (es) |
| KR (2) | KR20040004406A (es) |
| CN (1) | CN1255059A (es) |
| AP (1) | AP9801234A0 (es) |
| AR (2) | AR011726A1 (es) |
| AU (1) | AU6932198A (es) |
| BG (1) | BG103852A (es) |
| BR (1) | BR9808720A (es) |
| CA (1) | CA2288759A1 (es) |
| DZ (1) | DZ2479A1 (es) |
| EA (1) | EA003696B1 (es) |
| GT (1) | GT199800063A (es) |
| HR (1) | HRP980244A2 (es) |
| HU (1) | HUP0001286A3 (es) |
| ID (1) | ID21311A (es) |
| IL (1) | IL132570A0 (es) |
| IS (1) | IS5220A (es) |
| MA (1) | MA26491A1 (es) |
| NO (1) | NO995389L (es) |
| NZ (1) | NZ500183A (es) |
| OA (1) | OA11213A (es) |
| PA (1) | PA8450601A1 (es) |
| PE (1) | PE72599A1 (es) |
| PL (1) | PL337003A1 (es) |
| SK (1) | SK148199A3 (es) |
| TN (1) | TNSN98059A1 (es) |
| TW (1) | TW590773B (es) |
| UY (1) | UY24989A1 (es) |
| WO (1) | WO1998050033A1 (es) |
| YU (1) | YU55899A (es) |
| ZA (1) | ZA983722B (es) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6245797B1 (en) | 1997-10-22 | 2001-06-12 | Merck & Co., Inc. | Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease |
| AU2003204888B2 (en) * | 1998-05-22 | 2005-07-28 | Pfizer Products Inc. | Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives |
| US6506785B2 (en) | 1998-05-22 | 2003-01-14 | Pfizer, Inc. | Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives |
| JP2002528413A (ja) * | 1998-10-23 | 2002-09-03 | メルク フロスト カナダ アンド カンパニー | Ｅ型プロスタグランジンリガンド及びｃｏｘ−２選択的阻害剤を含む配合剤及び使用方法 |
| JP2002538189A (ja) * | 1999-03-10 | 2002-11-12 | ジー．ディー．サール アンド カンパニー | シクロオキシゲナーゼ−２インヒビターの投与方法と組成物 |
| WO2001034204A1 (en) * | 1999-11-11 | 2001-05-17 | Eli Lilly And Company | Oncolytic combinations for the treatment of cancer |
| CA2407469A1 (en) * | 2000-05-15 | 2001-11-22 | Merck Frosst Canada & Co. | Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
| AU6837701A (en) | 2000-06-13 | 2001-12-24 | American Home Prod | Analgesic and anti-inflammatory compositions containing cox-2 inhibitors |
| DE10032132A1 (de) * | 2000-07-01 | 2002-01-17 | Lohmann Therapie Syst Lts | Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung |
| DE60137335D1 (de) | 2000-08-07 | 2009-02-26 | Univ Vanderbilt | Nachweis der COX-2 Aktivität und von Anandamid-Metaboliten |
| US20040209959A1 (en) * | 2001-07-16 | 2004-10-21 | Edward Hogestatt | Congeners of acetaminophen and related compounds as substrates for fatty acid conjugation and their use in treatment of pain, fever and inflammation |
| DE602004002832T2 (de) | 2003-05-07 | 2007-06-06 | Osteologix A/S | Behandlung von knorpel/knochen-erkrankungen mit wasserlöslichen strontiumsalzen |
| CA2533101A1 (en) * | 2003-07-31 | 2005-02-03 | Pharmacia & Upjohn Company Llc | Dispersible formulation of an anti-inflammatory agent |
| CA2608010A1 (en) * | 2005-05-20 | 2006-11-23 | Pfizer Limited | Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-delta-ligands |
| CN103120653B (zh) | 2007-04-04 | 2015-09-30 | 希格默伊德药业有限公司 | 一种口服药物组合物 |
| CA2685118C (en) | 2007-04-26 | 2016-11-01 | Sigmoid Pharma Limited | Manufacture of multiple minicapsules |
| JP5640079B2 (ja) | 2009-05-18 | 2014-12-10 | シグモイド・ファーマ・リミテッドＳｉｇｍｏｉｄ Ｐｈａｒｍａ Ｌｉｍｉｔｅｄ | 油滴含有組成物 |
| CN102573802A (zh) | 2009-08-12 | 2012-07-11 | 希格默伊德药业有限公司 | 包含聚合物基质和油相的免疫调节组合物 |
| GB201020032D0 (en) | 2010-11-25 | 2011-01-12 | Sigmoid Pharma Ltd | Composition |
| GB201212010D0 (en) | 2012-07-05 | 2012-08-22 | Sigmoid Pharma Ltd | Formulations |
| GB201319791D0 (en) | 2013-11-08 | 2013-12-25 | Sigmoid Pharma Ltd | Formulations |
| US12109218B2 (en) | 2014-12-09 | 2024-10-08 | Aratana Therapeutics, Inc. | Compositions of grapiprant and methods for using the same |
| DK3113774T3 (da) * | 2014-03-06 | 2022-03-07 | Elanco Animal Health Incorporated | Sammensætninger af grapiprant og fremgangsmåder til anvendelse deraf |
| PT3215127T (pt) | 2014-11-07 | 2021-02-10 | Sublimity Therapeutics Ltd | Composições que compreendem ciclosporina |
| EP3242557A4 (en) * | 2015-01-09 | 2018-09-05 | Jaguar Health, Inc. | Methods of treating diarrhea in companion animals |
| US20230174485A1 (en) * | 2020-03-25 | 2023-06-08 | Sri International | Lipoxygenase inhibitors |
| US11116737B1 (en) | 2020-04-10 | 2021-09-14 | University Of Georgia Research Foundation, Inc. | Methods of using probenecid for treatment of coronavirus infections |
| KR102404883B1 (ko) | 2020-11-30 | 2022-06-07 | (주)이노보테라퓨틱스 | 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3896145A (en) * | 1972-07-24 | 1975-07-22 | Hoffmann La Roche | Carbazoles |
| CA1319886C (en) * | 1987-02-03 | 1993-07-06 | Alberto Ferro | Mixed micelle solutions |
-
1998
- 1998-03-02 DZ DZ980089A patent/DZ2479A1/xx active
- 1998-04-30 TW TW087106689A patent/TW590773B/zh not_active IP Right Cessation
- 1998-05-01 KR KR10-2003-7005258A patent/KR20040004406A/ko not_active Ceased
- 1998-05-01 SK SK1481-99A patent/SK148199A3/sk unknown
- 1998-05-01 HU HU0001286A patent/HUP0001286A3/hu unknown
- 1998-05-01 IL IL13257098A patent/IL132570A0/xx unknown
- 1998-05-01 BR BR9808720-7A patent/BR9808720A/pt not_active IP Right Cessation
- 1998-05-01 YU YU55899A patent/YU55899A/sh unknown
- 1998-05-01 CA CA002288759A patent/CA2288759A1/en not_active Abandoned
- 1998-05-01 KR KR1019997010252A patent/KR20010012300A/ko not_active Ceased
- 1998-05-01 EA EA199900895A patent/EA003696B1/ru not_active IP Right Cessation
- 1998-05-01 NZ NZ500183A patent/NZ500183A/en unknown
- 1998-05-01 WO PCT/IB1998/000662 patent/WO1998050033A1/en not_active Ceased
- 1998-05-01 JP JP10547869A patent/JP2000513020A/ja active Pending
- 1998-05-01 EP EP98915041A patent/EP0988034A1/en not_active Withdrawn
- 1998-05-01 PL PL98337003A patent/PL337003A1/xx unknown
- 1998-05-01 AU AU69321/98A patent/AU6932198A/en not_active Abandoned
- 1998-05-01 CN CN98804845A patent/CN1255059A/zh active Pending
- 1998-05-01 ID IDP980651A patent/ID21311A/id unknown
- 1998-05-04 MA MA25059A patent/MA26491A1/fr unknown
- 1998-05-04 GT GT199800063A patent/GT199800063A/es unknown
- 1998-05-04 UY UY24989A patent/UY24989A1/es not_active Application Discontinuation
- 1998-05-04 TN TNTNSN98059A patent/TNSN98059A1/fr unknown
- 1998-05-04 PE PE1998000335A patent/PE72599A1/es not_active Application Discontinuation
- 1998-05-04 AP APAP/P/1998/001234A patent/AP9801234A0/en unknown
- 1998-05-04 ZA ZA9803722A patent/ZA983722B/xx unknown
- 1998-05-05 HR HR60/045,635A patent/HRP980244A2/hr not_active Application Discontinuation
- 1998-05-05 PA PA19988450601A patent/PA8450601A1/es unknown
- 1998-05-05 AR ARP980102089A patent/AR011726A1/es unknown
-
1999
- 1999-10-19 IS IS5220A patent/IS5220A/is unknown
- 1999-11-02 OA OA9900242A patent/OA11213A/en unknown
- 1999-11-03 BG BG103852A patent/BG103852A/xx unknown
- 1999-11-04 NO NO995389A patent/NO995389L/no not_active Application Discontinuation
-
2003
- 2003-04-09 AR ARP030101251A patent/AR039628A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8450601A1 (es) | Carprofeno selectivo para cox-2, para el tratamiento del dolor e inflamacion en perros | |
| BRPI0411924A (pt) | métodos e dispositivos para oclusão de lúmens de corpo e/ou para fornecimento de agentes terapêuticos | |
| ES2096312T3 (es) | Derivado de quinuclidina como antagonista de la sustancia p. | |
| ES2099977T3 (es) | Composiciones de liberacion prolongada para tratar enfermedades periodontales. | |
| ATE397441T1 (de) | Schmelzextrudierte oral verabreichbare hydromorphoneformulierungen | |
| ES2171933T3 (es) | Derivados de androsteno. | |
| NO981392L (no) | Substituerte pyrazolylbenzensulfonamider for anvendelse i veterinµrterapi som antiinflammatorisk middel | |
| PT100514A (pt) | 3-aminoquinuclidinas substituidas e composicoes farmaceuticas que qs contem | |
| MX9307185A (es) | Derivados de carboxilato de indol que inhiben la biosintesis del leucotrieno y composiciones farmaceuticas que los contienen. | |
| CL2004001046A1 (es) | COMPOSICION FARMACEUTICA QUE COMPRENDE UN 1er AGENTE TERAPEUTICO QUE ES UN ANTIPSICOTICO ATIPICO Y UN 2o AGENTE TERAPEUTICO SELECCIONADO DE AGENTES MODULADORES DE LOS RECEPTORES DEL GABA, AGENTES ANTICONVULSIVOS Y BENZODIAZEPINAS; USO PARA TRATAR TRA | |
| ES2189003T3 (es) | Enantiomeros 3-piridilo y su utilizacion como analgesicos. | |
| CR6210A (es) | Composiciones de celecoxib | |
| AR026610A1 (es) | Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central | |
| ITRM920270A0 (it) | Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale. | |
| ES2130152T3 (es) | Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto. | |
| AR024380A1 (es) | Tienopirimidinas | |
| ATE55549T1 (de) | Hygienische zusatzkappen fuer therapeutische lasergeraete. | |
| AR019579A1 (es) | USO DE UN INICIADOR DE LA RESPUESTA SEXUAL DEL SISTEMA NERVIOSO CENTRAL PARA LA FABRICACIoN DE UNA COMPOSICIoN FARMACÉUTICA PARA LA NORMALIZACIoN DE LA CRONOMETRACIoN DE LA RESPUESTA SEXUAL O PARA LA PROFILAXIS O REDUCCIoN DE LA LESIoN TISULAR GENITAL EN MAMíFEROS | |
| FI933975A0 (fi) | Tabletter som kontrollerat avgiver naproxen | |
| ES2136954T3 (es) | Utilizacion de al menos un agua termal de vichy como antagonista de sustancia p. | |
| NO20031650D0 (no) | Nye legemidler for leversykdommer | |
| AR008083A1 (es) | Composiciones farmaceuticas y el uso de compuestos para preparar medicamentos para tratar desordenes del snc. | |
| AR022348A1 (es) | Una composicion farmaceutica para el tratamiento de los sintomas del tracto urinario inferior | |
| PT834316E (pt) | Utilizacao da sulbutiamina para a obtencao de composicoes farmaceuticas uteis no tratamento de certas perturbacoes psicomotoras e psico-intelectuais | |
| HN1998000114A (es) | Carprofeno selectivo para cox-2, para el tratamiento del dolor e inflamacion en perros |